NCT05646290

Brief Summary

This study will validate a machine learning model for predicting anastomotic leakage of esophagogastrostomy and esophagojejunostomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
512

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2024

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

2.2 years

First QC Date

December 1, 2022

Last Update Submit

November 18, 2024

Conditions

Keywords

machine learninganastomotic leakagetotal and proximal gastrectomy

Outcome Measures

Primary Outcomes (1)

  • Incidence of anastomotic leakage

    Within 30 days after operation

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Gastric cancer patients undergoing total or proximal gastrectomy in five medical centers (Tongji Hospital, Wuhan No. 1 Hospital, Xianning Central Hospital, Huanggang Central Hospital and Jingzhou Central Hospital) are included in this perspective study.

You may qualify if:

  • Aged older than 18 years and younger than 85 years.
  • Primary gastric adenocarcinoma confirmed by preoperative pathology.
  • Expected curative resection via total or proximal gastrectomy.
  • American Society of Anesthesiologists (ASA) class I, II, or III.
  • Written informed consent.

You may not qualify if:

  • Pregnant or breastfeeding women.
  • Severe mental disorder or language communication disorder.
  • Other surgical procedures of gastrectomy is performed.
  • Interrupted of surgery for more than 30 minutes due to any cause.
  • Malignant tumors with other organs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

Wuhan, Hubei, 430030, China

Location

MeSH Terms

Conditions

Stomach NeoplasmsAnastomotic Leak

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 12, 2022

Study Start

January 6, 2022

Primary Completion

March 15, 2024

Study Completion

May 6, 2024

Last Updated

November 21, 2024

Record last verified: 2024-11

Locations